Search research articles
Contact Us
Filters
Showing results (91-100 of 95) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 95 results.
Journal of Neurology
|
December 12, 2024
Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis
Manuel Comabella, Harald Hegen, Luisa M Villar, et al.
The Lancet. Neurology
|
December 2, 2014
Thrombolysis and clinical outcome in patients with stroke after implementation of the Tyrol Stroke Pathway: a retrospective observational study
Johann Willeit, Theresa Geley, Johannes Schöch, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 8, 2023
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis
Nicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga, et al.
Multiple Sclerosis and Related Disorders
|
July 7, 2020
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
Daniel H Whittam, Alvaro Cobo-Calvo, A Sebastian Lopez-Chiriboga, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 12, 2025
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis
Ahmed Abdelhak, Franziska Bachhuber, Kiarra Ning, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 95) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 95 results.
Journal of Neurology
|
December 12, 2024
Increased EBNA1-specific antibody response in primary-progressive multiple sclerosis
Manuel Comabella, Harald Hegen, Luisa M Villar, et al.
The Lancet. Neurology
|
December 2, 2014
Thrombolysis and clinical outcome in patients with stroke after implementation of the Tyrol Stroke Pathway: a retrospective observational study
Johann Willeit, Theresa Geley, Johannes Schöch, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 8, 2023
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis
Nicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga, et al.
Multiple Sclerosis and Related Disorders
|
July 7, 2020
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
Daniel H Whittam, Alvaro Cobo-Calvo, A Sebastian Lopez-Chiriboga, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 12, 2025
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis
Ahmed Abdelhak, Franziska Bachhuber, Kiarra Ning, et al.
Page
of 10